These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38587418)

  • 1. TCF1highPD-1+Ly108+CD8+ T Cells Are Associated with Graft Preservation in Sensitized Mice Treated with Non-Fc Receptor-Binding CD3 Antibodies.
    Ota T; Goto R; Harada T; Forgioni A; Kanazawa R; Ganchiku Y; Kawamura N; Watanabe M; Fukai M; Shimamura T; Taketomi A
    Immunohorizons; 2024 Apr; 8(4):295-306. PubMed ID: 38587418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin.
    Vallera DA; Taylor PA; Panoskaltsis-Mortari A; Blazar BR
    Blood; 1995 Dec; 86(11):4367-75. PubMed ID: 7492798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
    J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells.
    Goto R; You S; Zaitsu M; Chatenoud L; Wood KJ
    Am J Transplant; 2013 Jul; 13(7):1655-64. PubMed ID: 23750800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.
    Sarangi PP; Kim B; Rouse BT
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5425-33. PubMed ID: 18689698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
    J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
    Ji H; Shen XD; Gao F; Busuttil RW; Zhai Y; Kupiec-Weglinski JW
    Transplantation; 2011 May; 91(10):1075-81. PubMed ID: 21427633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Du G; Yang N; Gong W; Fang Y; He J; Zhou N; Lu X; Zhao Y
    Exp Cell Res; 2017 Jun; 355(1):1-8. PubMed ID: 28232114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.
    Bumgardner GL; Li J; Prologo JD; Heininger M; Orosz CG
    Transplantation; 1999 Aug; 68(4):555-62. PubMed ID: 10480416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor IL-6 deficiency evidently reduces memory T cell responses in sensitized transplant recipients.
    Chen J; Liu C; Liu B; Kong D; Wen L; Gong W
    Transpl Immunol; 2018 Dec; 51():66-72. PubMed ID: 30287356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells.
    Goldstein DR; Chang T; Sweeney SD; Kirklin JK; Thomas JM; George JF
    Transplantation; 2000 Oct; 70(7):1068-73. PubMed ID: 11045644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
    Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
    J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipients.
    Shariff H; Tanriver Y; Brown KL; Meader L; Greenlaw R; Mamode N; Jurcevic S
    Transplantation; 2010 Aug; 90(3):270-8. PubMed ID: 20571468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.